Show simple item record

dc.contributor.authorBarker, Claire L
dc.contributor.authorKing, Jennifer
dc.contributor.authorColaco, Rovel J
dc.date.accessioned2022-11-30T10:21:16Z
dc.date.available2022-11-30T10:21:16Z
dc.date.issued2022en
dc.identifier.citationBarker CL, King J, Colaco R. Further Considerations in Regards to Commissioning of Spine Stereotactic Ablative Body Radiotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)). 2022 Nov 3. PubMed PMID: 36336578. Epub 2022/11/07. eng.en
dc.identifier.pmid36336578en
dc.identifier.doi10.1016/j.clon.2022.10.007en
dc.identifier.urihttp://hdl.handle.net/10541/625758
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.clon.2022.10.007en
dc.titleFurther considerations in regards to commissioning of spine stereotactic ablative body radiotherapyen
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.en
dc.identifier.journalClinical Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record